Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran
Background: Oral candidiasis is a common disease in cancer patients subject to chemotherapy. The aim of this study was to evaluate the risk factors of rising oral candidiasis incidence and to identify the Candida species isolated from oral lesions of cancer patients and their antifungal sensitivity....
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Advanced Biomedical Research |
| Subjects: | |
| Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2020;volume=9;issue=1;spage=50;epage=50;aulast=Maheronnaghsh |
| _version_ | 1818458954597924864 |
|---|---|
| author | Mehrnoush Maheronnaghsh Mahnaz Fatahinia Parvin Dehghan Ali Teimoori |
| author_facet | Mehrnoush Maheronnaghsh Mahnaz Fatahinia Parvin Dehghan Ali Teimoori |
| author_sort | Mehrnoush Maheronnaghsh |
| collection | DOAJ |
| description | Background: Oral candidiasis is a common disease in cancer patients subject to chemotherapy. The aim of this study was to evaluate the risk factors of rising oral candidiasis incidence and to identify the Candida species isolated from oral lesions of cancer patients and their antifungal sensitivity. Materials and Methods: A total of 645 patients with cancer were examined. Several Candida species were isolated from specimens and identified by morphological and molecular methods. The susceptibility of isolates to amphotericin B, fluconazole, and nystatin was also investigated. Results: A total of 74 isolates of Candida were recovered from oral cavity of 61 cancer patients with oral candidiasis. The isolates included Candida albicans (n = 56; 75.5%), Candida glabrata (n = 4; 5.4%), Candida krusei (n = 5; 7%), Candida tropical (n = 7; 9.4%), and Candida kefyr (n = 2; 2.7%). A total (n = 72; 98.65%) of isolates were susceptible to nystatin, (n = 58; 78.4%) of them were susceptible to fluconazole, and (n = 8; 10.8%) of susceptible dose-dependent isolates were specified, (n = 46; 62.16%) of isolates were susceptible to amphotericin B. Conclusion: Finally, in addition to emphasis on topical nystatin application in the first stage of oral candidiasis in these patients, using alternative systemic drugs such as fluconazole and amphotericin B can be considered for the resistant candida isolates to nystatin. |
| first_indexed | 2024-12-14T23:06:40Z |
| format | Article |
| id | doaj.art-3096fa92df7346358c5d50821b93be6a |
| institution | Directory Open Access Journal |
| issn | 2277-9175 |
| language | English |
| last_indexed | 2024-12-14T23:06:40Z |
| publishDate | 2020-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Advanced Biomedical Research |
| spelling | doaj.art-3096fa92df7346358c5d50821b93be6a2022-12-21T22:44:18ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752020-01-0191505010.4103/abr.abr_214_19Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of IranMehrnoush MaheronnaghshMahnaz FatahiniaParvin DehghanAli TeimooriBackground: Oral candidiasis is a common disease in cancer patients subject to chemotherapy. The aim of this study was to evaluate the risk factors of rising oral candidiasis incidence and to identify the Candida species isolated from oral lesions of cancer patients and their antifungal sensitivity. Materials and Methods: A total of 645 patients with cancer were examined. Several Candida species were isolated from specimens and identified by morphological and molecular methods. The susceptibility of isolates to amphotericin B, fluconazole, and nystatin was also investigated. Results: A total of 74 isolates of Candida were recovered from oral cavity of 61 cancer patients with oral candidiasis. The isolates included Candida albicans (n = 56; 75.5%), Candida glabrata (n = 4; 5.4%), Candida krusei (n = 5; 7%), Candida tropical (n = 7; 9.4%), and Candida kefyr (n = 2; 2.7%). A total (n = 72; 98.65%) of isolates were susceptible to nystatin, (n = 58; 78.4%) of them were susceptible to fluconazole, and (n = 8; 10.8%) of susceptible dose-dependent isolates were specified, (n = 46; 62.16%) of isolates were susceptible to amphotericin B. Conclusion: Finally, in addition to emphasis on topical nystatin application in the first stage of oral candidiasis in these patients, using alternative systemic drugs such as fluconazole and amphotericin B can be considered for the resistant candida isolates to nystatin.http://www.advbiores.net/article.asp?issn=2277-9175;year=2020;volume=9;issue=1;spage=50;epage=50;aulast=Maheronnaghshamphotericin bcandidachemotherapyfluconazolenystatinoral candidiasis |
| spellingShingle | Mehrnoush Maheronnaghsh Mahnaz Fatahinia Parvin Dehghan Ali Teimoori Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran Advanced Biomedical Research amphotericin b candida chemotherapy fluconazole nystatin oral candidiasis |
| title | Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran |
| title_full | Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran |
| title_fullStr | Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran |
| title_full_unstemmed | Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran |
| title_short | Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran |
| title_sort | identification of candida species and antifungal susceptibility in cancer patients with oral lesions in ahvaz southern west of iran |
| topic | amphotericin b candida chemotherapy fluconazole nystatin oral candidiasis |
| url | http://www.advbiores.net/article.asp?issn=2277-9175;year=2020;volume=9;issue=1;spage=50;epage=50;aulast=Maheronnaghsh |
| work_keys_str_mv | AT mehrnoushmaheronnaghsh identificationofcandidaspeciesandantifungalsusceptibilityincancerpatientswithorallesionsinahvazsouthernwestofiran AT mahnazfatahinia identificationofcandidaspeciesandantifungalsusceptibilityincancerpatientswithorallesionsinahvazsouthernwestofiran AT parvindehghan identificationofcandidaspeciesandantifungalsusceptibilityincancerpatientswithorallesionsinahvazsouthernwestofiran AT aliteimoori identificationofcandidaspeciesandantifungalsusceptibilityincancerpatientswithorallesionsinahvazsouthernwestofiran |